参考文献/References:
[1] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,36(6):521-545.
[2] Moussa ID,Mohananey D,Saucedo J,et al. Trends and outcomes of restenosis after coronary stent implantation in the United States[J]. J Am Coll Cardiol,2020,76(13):1521-1531.
[3] Sousa-Uva M,Neumann FJ,Ahlsson A,et al. 2018 ESC / EACTS Guidelines on myocardial revascularization[J]. Eur J Cardiothorac Surg,2019,55(1):4-90.
[4] Cassese S,Xu B,Habara S,et al. Incidence and predictors of reCurrent restenosis after drug-coated balloon Angioplasty for Restenosis of a drUg-eluting Stent: The ICARUS Cooperation[J]. Rev Esp Cardiol (Engl Ed),2018,71(8):620-627.
[5] Giacoppo D,Alfonso F,Xu B,et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis[J]. J Am Coll Cardiol,2020,75(21):2664-2678.
[6] Koiwaya H,Watanabe N,Kuriyama N,et al. Predictors of recurrent in-stent restenosis after paclitaxel-coated balloon angioplasty[J]. Circ J,2017,81(9):1286-1292.
[7] Theodoropoulos K,Mennuni MG,Dangas GD,et al. Resistant in-stent restenosis in the drug eluting stent era[J]. Catheter Cardiovasc Interv,2016,88(5):777-785.
[8] Ozawa M,Okamura A,Date M,et al. Third in-stent restenosis in sirolimus eluting stents: predictors of the next restenosis[J]. Catheter Cardiovasc Interv,2015,79(1):91-96.
[9] Ads A,Aks B,Am C,et al. Recurrent drug-eluting stent in-stent restenosis: a state-of-the-art review of pathophysiology,diagnosis,and management[J]. Cardiovasc Revasc Med,2020,21(9):1157-1163.
[10] Habara S,Kadota K,Shimada T,et al. Late restenosis after paclitaxel-coated balloon angioplasty occurs in patients with drug-eluting stent restenosis[J]. J Am Coll Cardiol,2015,66(1):14-22.
[11] Katsuya M,Takeshi T,Seiji H,et al. Optical coherence tomography predictors for recurrent restenosis after paclitaxel-coated balloon angioplasty for drug-eluting stent restenosis[J]. Circ J,2018,82(11):2820-2828.
[12] Ng J,Bourantas CV,Torii R,et al. Local hemodynamic forces after stenting: implications on restenosis and thrombosiss[J]. Arterioscler Thromb Vasc Biol,2017,37(12):2231-2242.
[13] Bidula S,Dhuna K,Helliwell R, et al. Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages[J]. Cell Death Dis,2019,10(12):882.
[14] Kassimis G,Raina T. Double-vessel very late stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian[J]. J Geriatr Cardiol,2018,15(10):639-643.
[15] Shlofmitz E,Iantorno M,Waksman R. Restenosis of drug-eluting stents:a new classification system based on disease mechanism to guide treatment and state-of-the-art review[J]. Circ Cardiovasc Interv ,2019,12(8):e007023.
[16] Shlofmitz E. Recurrent in-stent restenosis: overcoming obstacles with intravascular imaging guidance[J]. Cardiovasc Revasc Med,2021,22:34-35.
[17] Shlofmitz E,Torguson R,Zhang C,et al. Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study)[J]. Int J Cardiol,2021,340:17-21.
[18] Fujii K,Kawakami R,Hirota S. Histopathological validation of optical coherence tomography findings of the coronary arteries[J]. J Cardiol,2018,72(3):179-185.
[19] Jinnouchi H,Kuramitsu S,Shinozaki T,et al. Difference of tissue characteristics between early and late restenosis after second-generation drug-eluting stents implantation―An optical coherence tomography study[J]. Circ J,2017,81(4):450-457.
[20] 赵琳琳,于波. 冠状动脉血管内成像研究进展[J]. 中华老年心脑血管病杂志,2018,20(6):659-662.
[21] Zhang DM,Chen S. In-stent restenosis and a drug-coated balloon: insights from a clinical therapeutic strategy on coronary artery diseases[J]. Cardiol Res Pract,2020,2020:8104939.
[22] Kang SJ,Mintz GS,Park DW,et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis.[J]. Circ Cardiovasc Interv,2011,4(1):9-14.
[23] Kajiya T,Yamaguchi H,Takaoka J,et al. In-stent restenosis assessed by frequency-domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents[J]. Singapore Med J,2019,60(1):48-51.
[24] Kubo S,Kadota K,Otsuru S,et al. Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions[J]. EuroIntervention,2013,9(7):788-796.
相似文献/References:
[1]何晨,综述,袁晋青,等.冠状动脉支架置入术后再狭窄的治疗研究进展[J].心血管病学进展,2016,(4):350.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.006]
HE Chen,YUAN Jinqing.Current Treatment of In-stent Restenosis[J].Advances in Cardiovascular Diseases,2016,(8):350.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.006]
[2]陆鑫 张华.无载体含药物洗脱支架研究进展1[J].心血管病学进展,2019,(7):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
LU xinZHANG Hua.Polymer-free Drug-eluting Stent[J].Advances in Cardiovascular Diseases,2019,(8):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
[3]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(8):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[4]陈彭辉 李军山 何晋.血管内超声指导冠状动脉复杂病变的介入治疗进展[J].心血管病学进展,2020,(11):1140.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
CHEN Penghui,LI Junshan,HE Jin.Interventional Therapy for Complex Coronary Artery Lesions Guided by Intravascular Ultrasound[J].Advances in Cardiovascular Diseases,2020,(8):1140.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[5]贺彩红 荣晶晶 潘宏伟.定量血流分数在急性心肌梗死中的应用进展[J].心血管病学进展,2021,(4):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
HE Caihong,RONG Jingjing,PAN Hongwei.Progress in the Application of Quantitative Flow Ratio in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(8):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
[6]陈佳仑 李树仁.不同策略血栓抽吸对于急性ST段抬高心肌梗死患者的研究进展[J].心血管病学进展,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
CHEN Jialun,LI Shuren.Different Strategies of Thrombus Aspiration in Patients with Acute ST Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(8):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
[7]牛梦瑶 胡晓惠 张静.冠状动脉小血管病变中药物球囊的应用进展[J].心血管病学进展,2022,(1):68.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
NIU Mengyao,HU Xiaohui,ZHANG Jing.Application of Drug Balloon in Coronary Small Vessel Disease[J].Advances in Cardiovascular Diseases,2022,(8):68.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.018]
[8]赵代鑫?胡晓军?谭巨浪?裴畅.基于Meta分析对比药物涂层球囊与药物洗脱支架在细小冠状动脉疾病中的应用[J].心血管病学进展,2022,(1):82.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.021]
ZHAO Daixin,HU Xiaojun,TAN Julang,et al.Comparison of Application of Drug-Coated Balloon and Drug-Eluting Stent in Small Coronary Artery Disease Based on Meta Analysis[J].Advances in Cardiovascular Diseases,2022,(8):82.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.021]
[9]梁晨笛 秦纲.经皮冠状动脉介入诊疗中穿刺路径研究进展[J].心血管病学进展,2022,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
LIANG Chendi,QIN Gang.Puncture Routes in Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(8):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[10]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(8):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[11]徐怡 农家聪 郭雅洁 许田 尤威 吴向起 吴志明 孟培娜 贾海波 叶飞.药物洗脱支架植入术后边缘效应的研究进展[J].心血管病学进展,2022,(12):1083.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.006]
XU Yi,NONG Jiacong,GUO Yajie,et al.Edge Effect After Drug Eluting Stenting[J].Advances in Cardiovascular Diseases,2022,(8):1083.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.006]
[12]刘玉莹,杨斌.PCI术后损伤血管再内皮化延迟的机制与治疗研究综述[J].心血管病学进展,2024,(3):248.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.013]
LIU Yuying,YANG Bin.A Review of the mechanism and therapy of delayed re-endothelialization of injured vessels after PCI[J].Advances in Cardiovascular Diseases,2024,(8):248.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.013]